Skip to content
Open access

Multi-omic data integration improves the resolution of the molecular etiology of autism in a mouse model.

Jul 2026 · Molecular Psychiatry · 0 citations · 59 references
Medicine

TL;DR

RNA-sequencing, 3-dimensional protein-centric chromatin conformation, and whole genome DNA methylation sequencing approaches are used to investigate hippocampal tissue from an ASD mouse model to determine if multi-omic data integration improves the resolution of key molecular pathways contributing to the complex ASD phenotype.

Abstract

Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental disorder with complex molecular etiology. Since genetic causes account for less than 50% of ASD cases, novel approaches are required to overcome the challenges of characterizing genes and molecular pathways linking risk alleles to phenotype. Here we use RNA-sequencing, 3-dimensional protein-centric chromatin conformation (Hi-ChIP), and whole genome DNA methylation sequencing approaches to investigate hippocampal tissue from an ASD mouse model (Cntnap2 knockout [Cntnap2 KO]) to determine if multi-omic data integration improves the resolution of key molecular pathways contributing to the complex ASD phenotype. Each -omic dataset individually identified disruptions in numerous genes and pathways, providing broad ASD-related insights, such as 1) 699 downregulated genes with an enrichment of neuronal ontological terms; 2) unique chromatin interactions in Cntnap2 KO mice; and 3) that most differentially methylated genes (1220/1659) have a neuronal function. The multi-omic data integration reduced the heterogeneity and refined the data to 43 genes with links to ASD (e.g., Zbtb18, Cttnbp2, Gabbr2). A pathways analysis of these 43 genes identified one gene ontological term: regulation of neuronal synaptic plasticity. These findings are consistent with large scale gene expression studies of human ASD postmortem brain tissue, suggesting that multi-omic data integration can be used to achieve a greater resolution of the heterogeneous ASD molecular etiology.

Read PDF

Similar papers

Aug 2026

Identification of EIF4A1 as a candidate molecular indicator of autism spectrum disorder using integrative bioinformatic and biological methods.

This study integrated mRNA expression profiles from five post-mortem brain tissue GEO datasets to identify ASD-associated genes and found that EIF4A1 mRNA expression was significantly elevated in ASD subjects and rescued by treatment with the antipsychotics olanzapine or risperidone.

Siru Dai, Kaiyang Zou, Guosen Lv et al. · 0 citations
Open access Aug 2026

An integrated systems biology and machine learning framework for identifying potential biomarkers and pathways in autism spectrum disorder

Findings indicate that CASP4 and TLR8, together with their associated regulatory miRNAs, may represent promising biomarkers and potential therapeutic targets for future ASD research and contribute to a better understanding of the pathophysiological mechanisms underlying ASD.

Sara Hosseinpoor, H. Zali, Hassan Zohrevand et al. · 0 citations
Open access Jul 2026

Circulating neuronal proteins are elevated in severe autism and associated with patient-specific neuronal dysfunction and behavioral deficits.

Key links between peripheral protein dysregulation and neuronal function and behavior are revealed, offering new insights into systemic contributions to ASD pathophysiology and highlighting potential therapeutic targets for mitigating symptom severity.

Samia M. Ltaief, Safa Salim, Sadam Hussain et al. · 0 citations
Open access Jul 2026

A placental transcriptional signature for autism

Using a nested case-cohort design within an Australian population-derived prebirth cohort study, placental transcriptomic signature of impaired mitochondrial function and gene transcription regulation among infants subsequently diagnosed with autism has profound implications for understanding both risk factors and pred...

L. Sominsky, A.-L. Ponsonby, M. O’Hely et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.